Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagene (ADAG) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Adagene (ADAG) over the last 6 years, with Q2 2025 value amounting to $66.5 million.

  • Adagene's Liabilities and Shareholders Equity fell 3399.78% to $66.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $372.3 million, marking a year-over-year increase of 91.76%. This contributed to the annual value of $89.3 million for FY2024, which is 2286.41% down from last year.
  • Latest data reveals that Adagene reported Liabilities and Shareholders Equity of $66.5 million as of Q2 2025, which was down 3399.78% from $89.3 million recorded in Q4 2024.
  • In the past 5 years, Adagene's Liabilities and Shareholders Equity ranged from a high of $217.9 million in Q2 2021 and a low of $135.3 during Q2 2023
  • Over the past 5 years, Adagene's median Liabilities and Shareholders Equity value was $100.8 million (recorded in 2024), while the average stood at $103.6 million.
  • As far as peak fluctuations go, Adagene's Liabilities and Shareholders Equity crashed by 9999.99% in 2022, and later surged by 7448468393.53% in 2024.
  • Adagene's Liabilities and Shareholders Equity (Quarter) stood at $189.5 million in 2021, then decreased by 19.58% to $152.4 million in 2022, then dropped by 24.06% to $115.7 million in 2023, then dropped by 22.86% to $89.3 million in 2024, then dropped by 25.49% to $66.5 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $66.5 million for Q2 2025, versus $89.3 million for Q4 2024 and $100.8 million for Q2 2024.